Edition:
India

Genmab A/S (GEN.CO)

GEN.CO on Copenhagen Stock Exchange

907.80DKK
15 Oct 2018
Change (% chg)

kr.-14.40 (-1.56%)
Prev Close
kr.922.20
Open
kr.929.00
Day's High
kr.929.00
Day's Low
kr.885.40
Volume
196,790
Avg. Vol
177,603
52-wk High
kr.1,443.00
52-wk Low
kr.846.00

Chart for

About

Genmab A/S is a Denmark-based biotechnology company. It is engaged in the development of differentiated human antibody therapeutics for the treatment of cancer, as well as other medical conditions, such as relapsing remitting multiple sclerosis. Its product pipeline includes a number of research and development projects in... (more)

Overall

Beta: 1.27
Market Cap(Mil.): kr.85,016.77
Shares Outstanding(Mil.): 61.16
Dividend: --
Yield (%): --

Financials

Danish biotech Genmab hit by ending of trial using key cancer drug

COPENHAGEN Shares in Danish biotech Genmab fell by as much as 25 percent on Monday after its partner Johnson & Johnson decided to ditch a study using its blockbuster cancer drug.

28 May 2018

BRIEF-Genmab: Q1 Net Sales Of Darzalex At $432 Mln

* REG-GENMAB ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR FIRST QUARTER OF 2018

17 Apr 2018

Earnings vs. Estimates